There are errors in the Correction published on April 8, 2021. The corrected figures are incorrect. The correct figures are:
Fig 1.
Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in different regions of Peru.
Fig 2.
Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in urban and rural areas of Peru.
Fig 3.
Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B).
Fig 4. Prevalence of anti-HBc IgG after the implementation of the hepatitis B vaccination program in Peru.

Fig 5. Prevalence of anti-HEV IgG in Peru, 2014–2015.

The publisher apologizes for the errors.
References
- 1.Cabezas C, Trujillo O, Gonzales-Vivanco Á, Benites Villafane CM, Balbuena J, Borda-Olivas AO, et al. (2020) Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 15(6): e0234273. 10.1371/journal.pone.0234273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.The PLOS ONE Staff (2021) Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 16(4): e0250185. 10.1371/journal.pone.0250185 [DOI] [PMC free article] [PubMed] [Google Scholar]



